Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BJ2

TCR589 in complex with HIV(Pol448-456)/HLA-B35

6BJ2 の概要
エントリーDOI10.2210/pdb6bj2/pdb
関連するPDBエントリー6BJ3 6BJ8
分子名称TCR 589 alpha chain, TCR 589 beta chain, HLA class I histocompatibility antigen, B-35 alpha chain, ... (9 entities in total)
機能のキーワードagonist, complex, immune system
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数5
化学式量合計96017.01
構造登録者
Jude, K.M.,Sibener, L.V.,Garcia, K.C. (登録日: 2017-11-03, 公開日: 2018-07-25, 最終更新日: 2024-10-23)
主引用文献Sibener, L.V.,Fernandes, R.A.,Kolawole, E.M.,Carbone, C.B.,Liu, F.,McAffee, D.,Birnbaum, M.E.,Yang, X.,Su, L.F.,Yu, W.,Dong, S.,Gee, M.H.,Jude, K.M.,Davis, M.M.,Groves, J.T.,Goddard III, W.A.,Heath, J.R.,Evavold, B.D.,Vale, R.D.,Garcia, K.C.
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.
Cell, 174:672-687.e27, 2018
Cited by
PubMed Abstract: TCR-signaling strength generally correlates with peptide-MHC binding affinity; however, exceptions exist. We find high-affinity, yet non-stimulatory, interactions occur with high frequency in the human T cell repertoire. Here, we studied human TCRs that are refractory to activation by pMHC ligands despite robust binding. Analysis of 3D affinity, 2D dwell time, and crystal structures of stimulatory versus non-stimulatory TCR-pMHC interactions failed to account for their different signaling outcomes. Using yeast pMHC display, we identified peptide agonists of a formerly non-responsive TCR. Single-molecule force measurements demonstrated the emergence of catch bonds in the activating TCR-pMHC interactions, correlating with exclusion of CD45 from the TCR-APC contact site. Molecular dynamics simulations of TCR-pMHC disengagement distinguished agonist from non-agonist ligands based on the acquisition of catch bonds within the TCR-pMHC interface. The isolation of catch bonds as a parameter mediating the coupling of TCR binding and signaling has important implications for TCR and antigen engineering for immunotherapy.
PubMed: 30053426
DOI: 10.1016/j.cell.2018.06.017
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.35 Å)
構造検証レポート
Validation report summary of 6bj2
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon